Edges in Network
Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
Node | ADAM15 |
Upstream (Parents) |
---|
(<<) CDK5 → ADAM15 |
(<<) CLPP → ADAM15 |
(<<) DHCR7 → ADAM15 |
(<<) DHRS9 → ADAM15 |
(<<) DLAT → ADAM15 |
(<<) ELOVL1 → ADAM15 |
(<<) ENO1 → ADAM15 |
(<<) GNG10 → ADAM15 |
(<<) GOT1 → ADAM15 |
(<<) GRPEL1 → ADAM15 |
(<<) GYPC → ADAM15 |
(<<) HSP90AB1 → ADAM15 |
(<<) KCNJ2 → ADAM15 |
(<<) LCP1 → ADAM15 |
(<<) LPXN → ADAM15 |
(<<) MAPKAPK5 → ADAM15 |
(<<) MKNK1 → ADAM15 |
(<<) PFDN2 → ADAM15 |
(<<) PIK3C3 → ADAM15 |
(<<) PRKCSH → ADAM15 |
(<<) PTPRE → ADAM15 |
(<<) RAD51L3 → ADAM15 |
(<<) RHOG → ADAM15 |
(<<) RRP9 → ADAM15 |
(<<) STAT4 → ADAM15 |
(<<) TUBB2C → ADAM15 |
(<<) UAP1 → ADAM15 |
Downstream (Children) |
---|
ADAM15 → AKT2 (>>) |
ADAM15 → ARSD (>>) |
ADAM15 → BMP1 (>>) |
ADAM15 → BMPR2 (>>) |
ADAM15 → CAPRIN2 (>>) |
ADAM15 → CDCP1 (>>) |
ADAM15 → CRCT1 (>>) |
ADAM15 → CRK (>>) |
ADAM15 → DEAF1 (>>) |
ADAM15 → EBP (>>) |
ADAM15 → ENO2 (>>) |
ADAM15 → ERBB2 (>>) |
ADAM15 → FADS2 (>>) |
ADAM15 → FGF5 (>>) |
ADAM15 → FZD1 (>>) |
ADAM15 → GNAL (>>) |
ADAM15 → GNAQ (>>) |
ADAM15 → GRB2 (>>) |
ADAM15 → IL1F5 (>>) |
ADAM15 → INE1 (>>) |
ADAM15 → LIMK1 (>>) |
ADAM15 → LSM1 (>>) |
ADAM15 → MAN2A2 (>>) |
ADAM15 → MAP2K2 (>>) |
ADAM15 → MAP3K6 (>>) |
ADAM15 → MTAP (>>) |
ADAM15 → NDST1 (>>) |
ADAM15 → NET1 (>>) |
ADAM15 → NRIP3 (>>) |
ADAM15 → OGFR (>>) |
ADAM15 → PGF (>>) |
ADAM15 → PHLDA1 (>>) |
ADAM15 → PHLDA2 (>>) |
ADAM15 → PITPNA (>>) |
ADAM15 → PITPNC1 (>>) |
ADAM15 → PKM2 (>>) |
ADAM15 → PPIB (>>) |
ADAM15 → RAC3 (>>) |
ADAM15 → RCAN1 (>>) |
ADAM15 → RRAS (>>) |
ADAM15 → RRP1 (>>) |
ADAM15 → SFN (>>) |
ADAM15 → SHC1 (>>) |
ADAM15 → SPRR2C (>>) |
ADAM15 → TAGLN2 (>>) |
ADAM15 → TP53 (>>) |
ADAM15 → TYRO3 (>>) |
ADAM15 → VEGFA (>>) |